Literature DB >> 20425527

Cyclophosphamide: a novel treatment of gastric antral vascular ectasia associated with systemic sclerosis?

Alicia Peterson1, John Varga.   

Abstract

Entities:  

Year:  2010        PMID: 20425527     DOI: 10.1007/s11926-009-0077-2

Source DB:  PubMed          Journal:  Curr Rheumatol Rep        ISSN: 1523-3774            Impact factor:   4.592


× No keyword cloud information.
  17 in total

Review 1.  Gastric antral vascular ectasia in systemic sclerosis: complete resolution with methylprednisolone and cyclophosphamide.

Authors:  A R Lorenzi; A H Johnson; G Davies; A Gough
Journal:  Ann Rheum Dis       Date:  2001-08       Impact factor: 19.103

2.  Phase I/II trial of autologous stem cell transplantation in systemic sclerosis: procedure related mortality and impact on skin disease.

Authors:  M Binks; J R Passweg; D Furst; P McSweeney; K Sullivan; C Besenthal; J Finke; H H Peter; J van Laar; F C Breedveld; W E Fibbe; D Farge; E Gluckman; F Locatelli; A Martini; F van den Hoogen; L van de Putte; A V Schattenberg; R Arnold; P A Bacon; P Emery; I Espigado; B Hertenstein; F Hiepe; A Kashyap; I Kötter; A Marmont; A Martinez; M J Pascual; A Gratwohl; H G Prentice; C Black; A Tyndall
Journal:  Ann Rheum Dis       Date:  2001-06       Impact factor: 19.103

3.  Cyclophosphamide versus placebo in scleroderma lung disease.

Authors:  Donald P Tashkin; Robert Elashoff; Philip J Clements; Jonathan Goldin; Michael D Roth; Daniel E Furst; Edgar Arriola; Richard Silver; Charlie Strange; Marcy Bolster; James R Seibold; David J Riley; Vivien M Hsu; John Varga; Dean E Schraufnagel; Arthur Theodore; Robert Simms; Robert Wise; Fredrick Wigley; Barbara White; Virginia Steen; Charles Read; Maureen Mayes; Ed Parsley; Kamal Mubarak; M Kari Connolly; Jeffrey Golden; Mitchell Olman; Barri Fessler; Naomi Rothfield; Mark Metersky
Journal:  N Engl J Med       Date:  2006-06-22       Impact factor: 91.245

4.  Two cases of gastric antral vascular ectasia--response to medical treatment.

Authors:  K Kishi; Y Kinoshita; N Kitajima; T Itoh; M Watanabe; C Kawanami; T Inadome; T Inoh; H Fukuzaki; M Fukase
Journal:  Gastroenterol Jpn       Date:  1991-12

5.  Pharmacotherapy for gastric antral vascular ectasia: dramatic response to tranexamic acid.

Authors:  Sujoy Khan; Asheesh Vaishnavi
Journal:  Gastrointest Endosc       Date:  2009-07       Impact factor: 9.427

6.  Antral vascular ectasia--the "watermelon" stomach.

Authors:  W D Rawlinson; G D Barr; B P Lin
Journal:  Med J Aust       Date:  1986-06-23       Impact factor: 7.738

7.  Treatment of chronic transfusion-dependent gastric antral vascular ectasia (watermelon stomach) with thalidomide.

Authors:  Kathryn A Dunne; J Hill; J F Dillon
Journal:  Eur J Gastroenterol Hepatol       Date:  2006-04       Impact factor: 2.566

8.  The clinical and endoscopic spectrum of the watermelon stomach.

Authors:  C J Gostout; T R Viggiano; D A Ahlquist; K K Wang; M V Larson; R Balm
Journal:  J Clin Gastroenterol       Date:  1992-10       Impact factor: 3.062

9.  Watermelon stomach in systemic sclerosis: its incidence and management.

Authors:  I Marie; P Ducrotte; M Antonietti; S Herve; H Levesque
Journal:  Aliment Pharmacol Ther       Date:  2008-05-21       Impact factor: 8.171

10.  Gastric antral vascular ectasia. A histologic and morphometric study of "the watermelon stomach".

Authors:  P F Suit; R E Petras; T W Bauer; J L Petrini
Journal:  Am J Surg Pathol       Date:  1987-10       Impact factor: 6.394

View more
  2 in total

1.  Successful treatment of refractory gastric antral vascular ectasia using transcatheter arterial embolization.

Authors:  Haruka Yoshida; Hiroki Takahashi; Hiromichi Akoshima; Nobuyuki Chida; Kenji Noguchi; Nobukazu Tanabe; Yutaka Mano; Katsuaki Ukai; Keiichi Tadokoro
Journal:  Clin J Gastroenterol       Date:  2013-05-23

Review 2.  Pharmacotherapy for the Treatment of Gastric Antral Vascular Ectasia: A Narrative Review.

Authors:  Mengyuan Peng; Xiaozhong Guo; Fangfang Yi; Fernando Gomes Romeiro; Andrea Mancuso; Xingshun Qi
Journal:  Adv Ther       Date:  2021-09-15       Impact factor: 3.845

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.